<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" 
        xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
  <url>
    <loc>https://www.openbell.ai/</loc>
    <lastmod>2026-10-12T13:48:23.231Z</lastmod>
    <changefreq>hourly</changefreq>
    <priority>1.0</priority>
  </url>
  <url>
    <loc>https://www.openbell.ai/support</loc>
    <lastmod>2026-10-12T13:48:23.231Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.7</priority>
  </url>
  <url>
    <loc>https://www.openbell.ai/privacy</loc>
    <lastmod>2026-10-12T13:48:23.231Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.openbell.ai/terms</loc>
    <lastmod>2026-10-12T13:48:23.231Z</lastmod>
    <changefreq>monthly</changefreq>
    <priority>0.5</priority>
  </url>
  <url>
    <loc>https://www.openbell.ai/feed.json</loc>
    <lastmod>2026-10-12T13:48:23.231Z</lastmod>
    <changefreq>hourly</changefreq>
    <priority>0.8</priority>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/PTGX:1791812825460</loc>
    <lastmod>2026-10-12T13:47:05.460Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/PTGX/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>UBS Initiates Coverage On Protagonist Therapeutics with Buy Rating, Announces Price Target of $184</image:title>
      <image:caption>UBS analyst Alice Nettleton has initiated coverage on Protagonist Therapeutics (NASDAQ: PTGX) with a Buy rating. The firm has set a price target of $184 for the company&#39;s stock.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/VYLR:1791812734736</loc>
    <lastmod>2026-10-12T13:45:34.736Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/VYLR/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>UBS Initiates Coverage On Vylor with Buy Rating, Announces Price Target of $89</image:title>
      <image:caption>UBS analyst Lucas Beaumont has initiated coverage on Vylor (NYSE: VYLR) with a Buy rating. The firm has set a price target of $89 for the stock.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/XRP:1791812708842</loc>
    <lastmod>2026-10-12T13:45:08.842Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/12/Warsaw--Poland---July-27--2021-View-Of-S.jpg?width=250&amp;height=187</image:loc>
      <image:title>Standard Chartered Launches RLUSD Custody as XRP Ledger Activity Surges</image:title>
      <image:caption>Standard Chartered has launched institutional custody services for Ripple&#39;s RLUSD stablecoin on the XRP Ledger, expanding its partnership with Ripple and LMAX Group. This service allows institutions to use RLUSD as trading collateral without transferring tokens directly to LMAX, aiming to reduce counterparty exposure and improve capital efficiency. The RLUSD is now operational through Standard Chartered&#39;s Dubai branch, regulated by the Dubai Financial Services Authority. This announcement follows the bank&#39;s plans to introduce digital asset custody services in Singapore for institutional clients.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/SVRN:1791812680849</loc>
    <lastmod>2026-10-12T13:44:40.849Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/SVRN/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Watching SVRN Inc.; Fugazi Research Issues Report On Co Titled, “SVRN: 100,000 to 1, the Ships Gone, the Audit Missing”</image:title>
      <image:caption>Fugazi Research has released a report on SVRN Inc., highlighting concerns about missing audits and significant discrepancies in the company&#39;s operations. The report suggests a troubling valuation of 100,000 to 1, indicating potential financial instability. Investors are advised to approach SVRN with caution given these findings.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/ODTX:1791812638994</loc>
    <lastmod>2026-10-12T13:43:58.994Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/ODTX/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>UBS Initiates Coverage On Odyssey Therapeutics with Buy Rating, Announces Price Target of $27</image:title>
      <image:caption>UBS analyst Alice Nettleton has initiated coverage on Odyssey Therapeutics (NASDAQ: ODTX) with a Buy rating. The firm has set a price target of $27 for the company&#39;s stock.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/ENVX:1791812479573</loc>
    <lastmod>2026-10-12T13:41:19.573Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/12/Portland--Or--Usa---Mar-12--2020-Dow-Jon.jpg?width=250&amp;height=187</image:loc>
      <image:title>US Stocks Mixed; Enovix Shares Jump</image:title>
      <image:caption>U.S. stocks showed mixed performance with the Dow Jones increasing by 0.4% to 51,842.74, while the NASDAQ fell by 0.16% to 27,322.33. Enovix Corp (NASDAQ: ENVX) shares surged following the announcement of a preliminary revenue of $11 million for Q3, marking a 38% year-over-year growth. In sector performance, energy shares rose by 1.5%, while information technology stocks declined by 0.4%.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/NOW:1791812387390</loc>
    <lastmod>2026-10-12T13:39:47.390Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/NOW/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>RBC Capital Maintains Outperform on ServiceNow, Raises Price Target to $176</image:title>
      <image:caption>RBC Capital analyst Matthew Hedberg has maintained an Outperform rating on ServiceNow (NYSE: NOW) and raised the price target from $130 to $176. This adjustment reflects a positive outlook on the company&#39;s performance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/SYRE:1791812355534</loc>
    <lastmod>2026-10-12T13:39:15.534Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/SYRE/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>UBS Initiates Coverage On Spyre Therapeutics with Buy Rating, Announces Price Target of $120</image:title>
      <image:caption>UBS analyst Alice Nettleton has initiated coverage on Spyre Therapeutics (NASDAQ: SYRE) with a Buy rating. The firm has set a price target of $120 for the company&#39;s stock.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/GD:1791812348415</loc>
    <lastmod>2026-10-12T13:39:08.415Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/GD/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Department Of War Certifies Production Capacity For Second Guided-Missile Destroyer At Maine&amp;#39;s Bath Iron Works</image:title>
      <image:caption>The Department of War has certified the production capacity for a second guided-missile destroyer at Bath Iron Works in Maine, a facility operated by General Dynamics (GD). This certification is a significant step in the production process, potentially impacting future defense contracts and revenue for the company. The announcement underscores the company&#39;s capabilities in naval shipbuilding amid ongoing military demands.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/MIRM:1791812305652</loc>
    <lastmod>2026-10-12T13:38:25.652Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/12/Medical-Research.jpg?width=250&amp;height=187</image:loc>
      <image:title>Why Is Mirum Pharmaceuticals Stock Gaining Monday?</image:title>
      <image:caption>Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) reported positive topline results from its Phase 3 EXPAND study for LIVMARLI (maralixibat), aimed at treating cholestatic pruritus in patients with ultra-rare liver conditions, including biliary atresia. The trial met its primary endpoint and showed significant improvements in itching and serum bile acids compared to placebo. Following the announcement, Mirum&#39;s stock rose by 2.31% to $88.00 during premarket trading.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/NXGL:1791812275701</loc>
    <lastmod>2026-10-12T13:37:55.701Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/NXGL/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>NexGel shares are trading lower after the company announced 1-for-20 reverse stock split effectiveness.</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/FFIV:1791812216132</loc>
    <lastmod>2026-10-12T13:36:56.132Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/FFIV/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>RBC Capital Maintains Outperform on F5, Raises Price Target to $525</image:title>
      <image:caption>RBC Capital analyst Matthew Hedberg has maintained an Outperform rating on F5 (NASDAQ: FFIV) and raised the price target from $508 to $525. This adjustment reflects a positive outlook on the company&#39;s performance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/DT:1791812149531</loc>
    <lastmod>2026-10-12T13:35:49.531Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/DT/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>RBC Capital Maintains Outperform on Dynatrace, Raises Price Target to $73</image:title>
      <image:caption>RBC Capital analyst Matthew Hedberg has maintained an Outperform rating on Dynatrace (NYSE: DT) and raised the price target from $59 to $73. This adjustment reflects a positive outlook for the company&#39;s performance in the market.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/DDOG:1791812092906</loc>
    <lastmod>2026-10-12T13:34:52.906Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/DDOG/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>RBC Capital Maintains Outperform on Datadog, Raises Price Target to $320</image:title>
      <image:caption>RBC Capital analyst Matthew Hedberg has maintained an &#39;Outperform&#39; rating on Datadog (NASDAQ: DDOG) and raised the price target from $280 to $320. This adjustment reflects a positive outlook on the company&#39;s performance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/TEAM:1791812016512</loc>
    <lastmod>2026-10-12T13:33:36.512Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/TEAM/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>RBC Capital Maintains Outperform on Atlassian, Raises Price Target to $235</image:title>
      <image:caption>RBC Capital analyst Matthew Hedberg has maintained an Outperform rating on Atlassian (NASDAQ: TEAM) and increased the price target from $215 to $235. This adjustment reflects a positive outlook for the company&#39;s performance in the market.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/USO:1791811994299</loc>
    <lastmod>2026-10-12T13:33:14.299Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/USO/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Reported Earlier: &amp;#39;OPEC Secretary General Haitham Al Ghais Says OPEC Has Revised ​down Its ‌oil Demand Growth Forecast For ​this Year ​to 400K BPD From ​1.4M ​BPD At The Start Of The ​year&amp;#39; - Reuters News</image:title>
      <image:caption>OPEC has revised its oil demand growth forecast for 2023, reducing it from 1.4 million barrels per day (BPD) to 400,000 BPD. This adjustment reflects changing market conditions and expectations. OPEC&#39;s Secretary General Haitham Al Ghais indicated that while demand growth is lower this year, there may be pent-up demand anticipated for 2027.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/AAPL:1791811978386</loc>
    <lastmod>2026-10-12T13:32:58.386Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/12/Apple-Ceo--Tim-Cook-Opens-The-Door-Of-Th.jpg?width=250&amp;height=187</image:loc>
      <image:title>Tim Cook Meets China’s Vice Premier as Apple Doubles Down on Its Biggest Overseas Market — Beijing Calls for ‘Stable’ US Ties</image:title>
      <image:caption>Apple Inc. Executive Chairman Tim Cook met with China&#39;s Vice Premier He Lifeng to discuss business cooperation and economic relations, emphasizing Apple&#39;s confidence in its long-term prospects in China. The Vice Premier highlighted the importance of stable U.S.-China ties for multinational companies and welcomed deeper cooperation with technology firms like Apple. Recent reports indicate that Apple is pursuing a China-specific AI strategy in collaboration with Alibaba and has seen a 12% year-over-year growth in iPhone 18 Pro sales, achieving a 33% smartphone market share in China.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/AI:1791811907989</loc>
    <lastmod>2026-10-12T13:31:47.989Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/12/C3-AIJakarta---September-17-2023-C3-ai-a.jpg?width=250&amp;height=187</image:loc>
      <image:title>C3.Ai Shares Edges Higher Monday: What&amp;#39;s Going On?</image:title>
      <image:caption>C3.Ai Inc. shares rose 6.50% to $12.28 following an upgrade from Northland, which increased its price target from $10 to $16. The upgrade highlights the potential of C3.Ai&#39;s new C3 Code platform, which can significantly reduce the development time for AI applications. In its first-quarter fiscal 2027 report, C3.Ai reported revenue of $52.4 million, a 25% decline year-over-year, but within its guidance range and slightly above analyst estimates.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/STTK:1791811898911</loc>
    <lastmod>2026-10-12T13:31:38.911Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/STTK/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>UBS Initiates Coverage On Shattuck Labs with Buy Rating, Announces Price Target of $17</image:title>
      <image:caption>UBS analyst Alice Nettleton has initiated coverage on Shattuck Labs (NASDAQ: STTK) with a Buy rating. The firm has set a price target of $17 for the company&#39;s stock.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/CWCO:1791811698889</loc>
    <lastmod>2026-10-12T13:28:18.889Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/CWCO/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Consolidated Water Wins $39.8M Contract To Build Advanced Water Purification Facility In Pismo Beach, CA</image:title>
      <image:caption>Consolidated Water Co. Ltd. (NASDAQ: CWCO) has secured a $39.8 million design-build contract from the City of Pismo Beach, California, for the Central Coast Blue Advanced Water Purification Facility. The project, awarded after a competitive procurement process, will enable PERC Water Corporation to design, construct, and test the facility, which will have an annual production capacity of approximately 750 acre-feet. The facility aims to provide a drought-resistant water supply and enhance the city&#39;s water reliability while protecting the local groundwater basin.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/HRMY:1791811670412</loc>
    <lastmod>2026-10-12T13:27:50.412Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/HRMY/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Needham Reiterates Buy on Harmony Biosciences Hldgs, Maintains $50 Price Target</image:title>
      <image:caption>Needham analyst Ami Fadia has reiterated a Buy rating on Harmony Biosciences Holdings (NASDAQ: HRMY) and maintained a price target of $50 for the stock.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/LOBO:1791811623619</loc>
    <lastmod>2026-10-12T13:27:03.619Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/LOBO/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Lobo Technologies Enters Agreement To Accelerate Development And Deployment Of AI-Powered Senior Care Solutions In China</image:title>
      <image:caption>Lobo Technologies has entered a strategic cooperation agreement with Land Crest Advisory Limited to enhance the development and deployment of AI-powered senior care solutions in China. Lobo will serve as the exclusive technology partner, providing a SaaS and IoT platform, AI data center, and smart hardware products, while Land Crest will focus on market expansion and community service development. The partnership aims to tap into China&#39;s projected RMB30 trillion silver economy, driven by an aging population and increasing demand for senior care services. The success of this initiative will depend on project execution, market adoption, and regulatory compliance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/ABCL:1791811415935</loc>
    <lastmod>2026-10-12T13:23:35.935Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/ABCL/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>UBS Initiates Coverage On AbCellera Biologics with Buy Rating, Announces Price Target of $18</image:title>
      <image:caption>UBS analyst Alice Nettleton has initiated coverage on AbCellera Biologics (NASDAQ: ABCL) with a Buy rating. The firm has set a price target of $18 for the company&#39;s stock.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/P:1791811364046</loc>
    <lastmod>2026-10-12T13:22:44.046Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/P/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Guggenheim Maintains Buy on Everpure, Raises Price Target to $215</image:title>
      <image:caption>Guggenheim analyst Howard Ma has maintained a &#39;Buy&#39; rating on Everpure (NYSE: P) and increased the price target from $150 to $215. This adjustment reflects a positive outlook for the company&#39;s future performance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/ELV:1791811239485</loc>
    <lastmod>2026-10-12T13:20:39.485Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/ELV/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Guggenheim Maintains Buy on Elevance Health, Raises Price Target to $460</image:title>
      <image:caption>Guggenheim analyst Jason Cassorla has maintained a Buy rating on Elevance Health (NYSE: ELV) and raised the price target from $455 to $460. This adjustment reflects a positive outlook for the company&#39;s stock performance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/OCUL:1791811215405</loc>
    <lastmod>2026-10-12T13:20:15.405Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/OCUL/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>UBS Initiates Coverage On Ocular Therapeutix with Buy Rating, Announces Price Target of $14</image:title>
      <image:caption>UBS analyst Alice Nettleton has initiated coverage on Ocular Therapeutix (NASDAQ: OCUL) with a Buy rating. The firm has set a price target of $14 for the company&#39;s stock.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/TROO:1791811078963</loc>
    <lastmod>2026-10-12T13:17:58.963Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/TROO/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>TROOPS Signs Conditional Agreement To Acquire EFFORCE, Expanding Digital Asset And Sustainability Ventures; Co-Founder Steve Wozniak To Remain Shareholder Of EFFORCE After Deal; No Terms Disclosed</image:title>
      <image:caption>TROOPS, Inc. has signed a conditional agreement to acquire EFFORCE Group, aiming to enhance its digital asset and sustainability ventures. The merger will combine TROOPS&#39; ecosystem with EFFORCE&#39;s blockchain technology and regulatory expertise, allowing access to new markets including carbon credit trading. Steve Wozniak will remain a shareholder of EFFORCE post-transaction. The deal is subject to regulatory approvals and customary closing conditions, with expectations of accelerated revenue growth and diversified income streams for TROOPS.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/ADBE:1791811050701</loc>
    <lastmod>2026-10-12T13:17:30.701Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/12/Adobe-Inc.jpg?width=250&amp;height=187</image:loc>
      <image:title>Wells Fargo Downgrades Adobe to Underweight, Says AI Survey Shows It Is Losing Budget Share</image:title>
      <image:caption>Wells Fargo has downgraded Adobe Inc. (NASDAQ: ADBE) from Overweight to Underweight and reduced its price target to $225, citing a survey indicating that Adobe is losing budget share in AI spending. The downgrade follows concerns over Adobe&#39;s third-quarter performance and the challenges it faces in achieving its fiscal 2027 guidance amid leadership changes. Wells Fargo now anticipates negative growth in new annual recurring revenue for fiscal 2027, with total annual recurring revenue growth projected at about 7%, below the consensus of over 8%. Following the announcement, Adobe shares fell 4.16% to $232.19.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/SLDE:1791811025411</loc>
    <lastmod>2026-10-12T13:17:05.411Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/SLDE/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Citizens Maintains Market Outperform on Slide Insurance Holdings, Raises Price Target to $28</image:title>
      <image:caption>Citizens analyst Matthew J. Carletti has maintained a Market Outperform rating on Slide Insurance Holdings (NASDAQ: SLDE) and has raised the price target from $27 to $28.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/ARAI:1791810948783</loc>
    <lastmod>2026-10-12T13:15:48.783Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/ARAI/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Arrive AI Forms Arrive AI Defense Division To Introduce Its Patented Autonomous Delivery Infrastructure And Intelligent Logistics Technologies To Defense, Military, Diplomatic, National Security Investors</image:title>
      <image:caption>Arrive AI (NASDAQ: ARAI) has established a new division called Arrive AI Defense, aimed at introducing its patented autonomous delivery infrastructure and intelligent logistics technologies to the defense, military, diplomatic, and national security sectors. This strategic move is intended to expand the company&#39;s market reach into these critical areas.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/LIFE:1791810943731</loc>
    <lastmod>2026-10-12T13:15:43.731Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/LIFE/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Citizens Maintains Market Outperform on Ethos Technologies, Raises Price Target to $40</image:title>
      <image:caption>Citizens analyst Matthew Carletti has maintained a Market Outperform rating on Ethos Technologies (NASDAQ: LIFE) and raised the price target from $33 to $40. This adjustment reflects a positive outlook on the company&#39;s performance in the market.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/IREN:1791810884009</loc>
    <lastmod>2026-10-12T13:14:44.009Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/12/IREN-Limited-Porto--Portugal---October-2.jpg?width=250&amp;height=187</image:loc>
      <image:title>IREN Scores Major AI Cloud Deal With Anthropic: Report</image:title>
      <image:caption>IREN Ltd. has secured a multi-year cloud contract with Anthropic, enhancing its AI data-center infrastructure and expanding its customer base. Anthropic plans to increase its AI computing capacity from 1.4 GW last year to over 15 GW by 2028, with agreements valued at approximately $530 billion across various cloud providers. Analysts have upgraded IREN&#39;s stock rating, with JPMorgan raising its price forecast to $65, anticipating annual recurring revenue of up to $4 billion by 2026. Following the news, IREN shares rose 4.46% to $36.76 in premarket trading.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/ALSN:1791810804636</loc>
    <lastmod>2026-10-12T13:13:24.636Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/ALSN/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Citigroup Upgrades Allison Transmission to Buy, Announces $135 Price Target</image:title>
      <image:caption>Citigroup analyst Kyle Menges has upgraded Allison Transmission (NYSE: ALSN) from Neutral to Buy, setting a price target of $135 for the stock. This upgrade reflects a positive outlook on the company&#39;s performance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/GOOG:1791810745262</loc>
    <lastmod>2026-10-12T13:12:25.262Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/GOOG/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Flo Health And Google Health Announce Multi-Year Partnership And Strategic Investment To Advance Personalized Women’s Health Insights; Details Of The Terms Not Disclosed</image:title>
      <image:caption>Flo Health has announced a multi-year partnership with Google Health, which includes a strategic investment from Google to enhance personalized women&#39;s health insights. The collaboration will enable users to sync their Flo app with Google Health starting in early 2027, allowing for deeper health insights and personalized guidance. Flo Health, which has over 80 million monthly users and half a billion downloads, emphasizes user data privacy and control, ensuring no data is shared without explicit user consent.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/MRVL:1791810695978</loc>
    <lastmod>2026-10-12T13:11:35.978Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/MRVL/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Marvell Technology Unveils Second-Generation Marvell Structera X 3406, Marvell Structera X 3506 CXL Memory Expanders</image:title>
      <image:caption>Marvell Technology, Inc. (NASDAQ: MRVL) has launched the second-generation Marvell Structera X 3406 and X 3506 CXL memory expanders. These products are aimed at enhancing efficiency and performance for cloud, enterprise, and AI infrastructure providers, particularly in hyperscale datacenters. The new memory expanders are designed to meet the growing demands of data center workloads in the evolving landscape of AI and computing.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/BXDC:1791810689839</loc>
    <lastmod>2026-10-12T13:11:29.839Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/BXDC/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Citigroup Upgrades Blackstone Digital Infr to Buy, Lowers Price Target to $20</image:title>
      <image:caption>Citigroup analyst Michael Rollins has upgraded Blackstone Digital Infrastructure (NYSE: BXDC) from Neutral to Buy. Additionally, the price target for the stock has been lowered from $23 to $20.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/NFLX:1791810678746</loc>
    <lastmod>2026-10-12T13:11:18.746Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/12/Los-Angeles---July-20--2025-Netflix-Sign.jpg?width=250&amp;height=187</image:loc>
      <image:title>Netflix’s Q3 Guidance Calls for About 12% Revenue Growth. Here’s the Bar for Oct. 20</image:title>
      <image:caption>Netflix Inc. (NASDAQ: NFLX) is set to report its third-quarter earnings on October 20, with analysts estimating earnings per share of 82 cents and revenue of $12.88 billion, reflecting approximately 12% growth. The company previously reported Q2 earnings of 80 cents per share on revenue of $12.56 billion, slightly missing expectations. Investors are particularly focused on revenue growth, advertising performance, and operating margin guidance of 33.2%, amid a backdrop of recent analyst downgrades and stock trading 14.6% below its 200-day moving average.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/FLEX:1791810615608</loc>
    <lastmod>2026-10-12T13:10:15.608Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/FLEX/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Flex Expands Its Portfolio Of Prefabricated Modular Data Center Solutions Designed To Accelerate Deployment Of Next-Generation AI Factories</image:title>
      <image:caption>Flex has expanded its portfolio of prefabricated modular data center solutions, introducing new AI Modules that can reduce deployment timelines by up to 50% compared to traditional construction. This expansion is part of Flex&#39;s Cloud and Power Infrastructure segment, which is set to be separated into an independent publicly traded company named Axiom by Q1 2027. The new modules include advanced features such as an 800 VDC Power Rack and liquid cooling systems, designed to meet the growing demands of AI infrastructure. Flex is also enhancing its manufacturing capacity for data centers, with over three million square feet dedicated to this purpose in the U.S.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/AII:1791810536185</loc>
    <lastmod>2026-10-12T13:08:56.185Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/AII/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Citizens Maintains Market Outperform on American Integrity, Raises Price Target to $29</image:title>
      <image:caption>Citizens analyst Matthew Carletti has maintained a Market Outperform rating on American Integrity (NYSE:AII) and raised the price target from $26 to $29. This adjustment reflects a positive outlook for the company in the market.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/GOAI:1791810505615</loc>
    <lastmod>2026-10-12T13:08:25.615Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/GOAI/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Maxim Group Initiates Coverage On Eva Live with Buy Rating, Announces Price Target of $7</image:title>
      <image:caption>Maxim Group analyst Jack Vander Aarde has initiated coverage on Eva Live (NASDAQ: GOAI) with a Buy rating. The firm has set a price target of $7 for the stock.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/MSFT:1791810387431</loc>
    <lastmod>2026-10-12T13:06:27.431Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/MSFT/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Microsoft To Expand Azure Maia System To Multi-Gigawatt Deployments; Expect Maia 300 To Deliver 40% More Tokens Per Megawatt Compared To Leading GPU-Based Systems</image:title>
      <image:caption>Microsoft announced plans to expand its Azure Maia system to multi-gigawatt deployments, aiming to enhance its cloud computing capabilities. The new Maia 300 system is expected to deliver 40% more tokens per megawatt compared to leading GPU-based systems, indicating significant efficiency improvements. This strategic move positions Microsoft to strengthen its competitive edge in the cloud market.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/POWI:1791810368066</loc>
    <lastmod>2026-10-12T13:06:08.066Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/POWI/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Power Integrations And Ideal Power Collaborate To Deliver Solid-State Circuit Breaker Solution Providing Efficient, Always-On Protection For 800 VDC AI Data Centers</image:title>
      <image:caption>Power Integrations (NASDAQ: POWI) and Ideal Power Inc. (NASDAQ: IPWR) have announced a collaboration to develop a solid-state circuit breaker (SSCB) solution aimed at enhancing protection and power conversion for 800 VDC AI data centers. The partnership will integrate Power Integrations&#39; 1700 V InnoMux-2 power conversion integrated circuits with Ideal Power&#39;s B-TRAN® switches to create a self-powered, intelligent SSCB. A working prototype has already been demonstrated, and the companies are currently developing a reference design.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/MRAM:1791810350398</loc>
    <lastmod>2026-10-12T13:05:50.398Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/MRAM/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Maxim Group Initiates Coverage On Everspin Technologies with Buy Rating, Announces Price Target of $25</image:title>
      <image:caption>Maxim Group analyst Jack Vander Aarde has initiated coverage on Everspin Technologies (NASDAQ: MRAM) with a Buy rating. The firm has set a price target of $25 for the company&#39;s stock.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/CMG:1791810330036</loc>
    <lastmod>2026-10-12T13:05:30.036Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/CMG/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Live On CNBC, Starbucks Tells Hosts &amp;#34;Not Buying Chipotle&amp;#34;</image:title>
      <image:caption>openbell Financial News</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/CISS:1791810327871</loc>
    <lastmod>2026-10-12T13:05:27.871Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/CISS/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>C3is Enters $175K/Day Voyage Charter Contract For Its Afrapearl II Aframax Tanker For 25 days; Company Estimates Its NAV/Share At $11.73</image:title>
      <image:caption>C3is has secured a voyage charter contract for its Afrapearl II Aframax tanker, valued at $175,000 per day for a duration of 25 days. The company also took delivery of its second MR Product Tanker in Q3 2026, increasing its total fleet capacity to 311,431 DWT. Additionally, C3is estimates its net asset value per share at $11.73.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/YSS:1791810298524</loc>
    <lastmod>2026-10-12T13:04:58.524Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/YSS/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>York Space Systems Receives U.S. Space Force’s Space Data Network Orders To Advance Advance Multi-Vendor Interoperability, Space Exchange Point Integration Planning</image:title>
      <image:caption>York Space Systems (NYSE: YSS) has received additional task orders from the U.S. Space Force to support the Space Data Network initiative. These orders focus on advancing multi-vendor interoperability and planning for Space Exchange Point integration. This development is part of York&#39;s ongoing efforts to enhance capabilities in national security and commercial space operations.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/SECZ:1791810226566</loc>
    <lastmod>2026-10-12T13:03:46.566Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/SECZ/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>StoneX Maintains Buy on Securitize Holdings, Raises Price Target to $18</image:title>
      <image:caption>StoneX analyst Mark Palmer has maintained a &#39;Buy&#39; rating on Securitize Holdings (NYSE: SECZ) and increased the price target from $12 to $18. This adjustment reflects a positive outlook on the company&#39;s performance.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/INSM:1791810219918</loc>
    <lastmod>2026-10-12T13:03:39.918Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/12/Konskie--Poland---December-08--2024-Insm.jpg?width=250&amp;height=187</image:loc>
      <image:title>This Insmed Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday</image:title>
      <image:caption>Wolfe Research analyst Andy Chen downgraded Insmed Inc (NASDAQ: INSM) from Outperform to Peer Perform, with shares closing at $100.60 on Friday. This downgrade is part of a broader trend, as several analysts have adjusted their ratings on various companies. The article highlights that Insmed is among the top five downgrades for the day.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/DT:1791810217689</loc>
    <lastmod>2026-10-12T13:03:37.689Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.brandfetch.io/DT/w/400/h/400?c=1idopYfmtR7ZKg8QMud</image:loc>
      <image:title>Dynatrace Awarded Initial Implementation Status From Federal Risk And Authorization Management Program</image:title>
      <image:caption>Dynatrace (NYSE: DT) has achieved &#39;Initial Implementation&#39; status for the Federal Risk and Authorization Management Program (FedRAMP) Class D (High) certification. This status indicates that the company is in the implementation stage of its FedRAMP journey, which will allow federal agencies to utilize Dynatrace&#39;s platform for monitoring and securing critical applications and infrastructure once full certification is obtained.</image:caption>
    </image:image>
  </url>
  <url>
    <loc>https://www.openbell.ai/news/NVDA:1791810206300</loc>
    <lastmod>2026-10-12T13:03:26.300Z</lastmod>
    <changefreq>daily</changefreq>
    <priority>0.9</priority>
    <image:image>
      <image:loc>https://cdn.benzinga.com/files/images/story/2026/10/12/AI-Bubble-Bursting.jpg?width=250&amp;height=187</image:loc>
      <image:title>Ray Dalio Says the AI Bubble Is Close to Bursting. A Strategist Says Zombie Companies Are the Real Risk</image:title>
      <image:caption>Ray Dalio, founder of Bridgewater Associates, has expressed concerns that the artificial intelligence (AI) market is approaching a bubble burst, primarily due to rising debt levels and interest rates, with the 10-year Treasury yield recently at 5.24%. In contrast, Jordi Visser of 22V Research argues that the real risk lies in &#39;zombie companies&#39; that are surviving on low borrowing costs but may struggle as rates increase. He notes that less than half of S&amp;P 500 stocks currently trade above their 200-day moving average, indicating market breadth issues despite the index nearing record highs.</image:caption>
    </image:image>
  </url>
</urlset>